GURUFOCUS.COM » STOCK LIST » Healthcare » Drug Manufacturers » Allergy Therapeutics PLC (LSE:AGY) » Definitions » Inventory Turnover

Allergy Therapeutics (LSE:AGY) Inventory Turnover : 1.11 (As of Dec. 2023)


View and export this data going back to 2004. Start your Free Trial

What is Allergy Therapeutics Inventory Turnover?

Inventory Turnover measures how fast the company turns over its inventory within a year. It is calculated as Cost of Goods Sold divided by Total Inventories. Allergy Therapeutics's Cost of Goods Sold for the six months ended in Dec. 2023 was £13.05 Mil. Allergy Therapeutics's Average Total Inventories for the quarter that ended in Dec. 2023 was £11.74 Mil. Allergy Therapeutics's Inventory Turnover for the quarter that ended in Dec. 2023 was 1.11.

Days Inventory indicates the number of days of goods in sales that a company has in the inventory. Allergy Therapeutics's Days Inventory for the six months ended in Dec. 2023 was 164.20.

Inventory-to-Revenue determines the ability of a company to manage their inventory levels. It measures the percentage of Inventories the company currently has on hand to support the current amount of Revenue. Allergy Therapeutics's Inventory-to-Revenue for the quarter that ended in Dec. 2023 was 0.35.


Allergy Therapeutics Inventory Turnover Historical Data

The historical data trend for Allergy Therapeutics's Inventory Turnover can be seen below:

* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD.
* For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.

* Premium members only.

Allergy Therapeutics Inventory Turnover Chart

Allergy Therapeutics Annual Data
Trend Jun14 Jun15 Jun16 Jun17 Jun18 Jun19 Jun20 Jun21 Jun22 Jun23
Inventory Turnover
Get a 7-Day Free Trial Premium Member Only Premium Member Only 2.02 2.07 2.11 2.09 2.29

Allergy Therapeutics Semi-Annual Data
Jun14 Dec14 Jun15 Dec15 Jun16 Dec16 Jun17 Dec17 Jun18 Dec18 Jun19 Dec19 Jun20 Dec20 Jun21 Dec21 Jun22 Dec22 Jun23 Dec23
Inventory Turnover Get a 7-Day Free Trial Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only 1.19 0.95 1.26 1.08 1.11

Allergy Therapeutics Inventory Turnover Calculation

Allergy Therapeutics's Inventory Turnover for the fiscal year that ended in Jun. 2023 is calculated as

Inventory Turnover (A: Jun. 2023 )
=Cost of Goods Sold / Average Total Inventories
=Cost of Goods Sold (A: Jun. 2023 ) / ((Total Inventories (A: Jun. 2022 ) + Total Inventories (A: Jun. 2023 )) / count )
=26.342 / ((11.41 + 11.593) / 2 )
=26.342 / 11.5015
=2.29

Allergy Therapeutics's Inventory Turnover for the quarter that ended in Dec. 2023 is calculated as

Inventory Turnover (Q: Dec. 2023 )
=Cost of Goods Sold / Average Total Inventories
=Cost of Goods Sold (Q: Dec. 2023 ) / ((Total Inventories (Q: Jun. 2023 ) + Total Inventories (Q: Dec. 2023 )) / count )
=13.052 / ((11.593 + 11.893) / 2 )
=13.052 / 11.743
=1.11

* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD.
* For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.


Allergy Therapeutics  (LSE:AGY) Inventory Turnover Explanation

Inventory Turnover measures how fast the company turns over its inventory within a year. A higher Inventory Turnover means the company has light inventory. Therefore the company spends less money on storage, write downs, and obsolete inventory. If the inventory is too light, it may affect sales because the company may not have enough to meet demand.

1. Days Inventory indicates the number of days of goods in sales that a company has in the inventory.

Allergy Therapeutics's Days Inventory for the six months ended in Dec. 2023 is calculated as:

Days Inventory =Average Total Inventories (Q: Dec. 2023 )/Cost of Goods Sold (Q: Dec. 2023 )*Days in Period
=11.743/13.052*365 / 2
=164.20

2. Inventory-to-Revenue determines the ability of a company to manage their inventory levels. It measures the percentage of Inventories the company currently has on hand to support the current amount of Revenue.

Allergy Therapeutics's Inventory to Revenue for the quarter that ended in Dec. 2023 is calculated as

Inventory-to-Revenue=Average Total Inventories (Q: Dec. 2023 ) / Revenue (Q: Dec. 2023 )
=11.743 / 33.572
=0.35

* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD.
* For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.


Be Aware

Usually retailers pile up their inventories at holiday seasons to meet the stronger demand. Therefore, the inventory of a particular quarter of a year should not be used to calculate Inventory Turnover. An average inventory is a better indication.


Allergy Therapeutics Inventory Turnover Related Terms

Thank you for viewing the detailed overview of Allergy Therapeutics's Inventory Turnover provided by GuruFocus.com. Please click on the following links to see related term pages.


Allergy Therapeutics (LSE:AGY) Business Description

Traded in Other Exchanges
Address
Dominion Way, Worthing, West Sussex, GBR, BN14 8SA
Allergy Therapeutics PLC is active in the healthcare sector in the United Kingdom. It is a pharmaceutical company mainly engaged in the treatment and prevention of allergies with aluminum-free products. The company's geographical segment includes Central Europe; Southern Europe and the Rest of the World. It generates maximum revenue from Central Europe which includes Germany and other countries.

Allergy Therapeutics (LSE:AGY) Headlines

No Headlines